Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population

被引:10
作者
Guo, Tie [1 ]
Hao, Haizhen [1 ]
Zhou, Lv [1 ]
Zhou, Feng [1 ]
Yu, Dan [1 ]
机构
[1] Cent S Univ, Xiangya Med Coll, Haikou Hosp, Haikou 570208, Hainan, Peoples R China
关键词
TIMP-2; single-nucleotide polymorphisms; large artery atherosclerotic stroke; southern Chinese Han population; ACUTE ISCHEMIC-STROKE; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; CANCER SUSCEPTIBILITY; INVOLVEMENT; PROGRESSION; POLYMORPHISMS; INSTABILITY; ACTIVATION; DISEASE;
D O I
10.18632/oncotarget.23473
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tissue inhibitor of matrix metalloproteinase 2 (TIMP-2) regulates the extracellular matrix degradation, which involved in vascular remodeling and dysfunction, destabilization of atherosclerotic plaque and many other pathological processes. The rupture of atherosclerotic plaque is the trigger of Large artery atherosclerotic (LAA) stroke. We speculate that the Single nucleotide polymorphisms (SNPs) in TIMP-2 may have an association with LAA stroke. To prove this hypothesis, we conducted this case-control study. 250 LAA stroke patients and 250 healthy controls were collected for the analysis of TIMP-2 polymorphisms. Among six SNPs, we detected no deviation from Hardy-Weinberg equilibrium in control group. There was a significant difference in rs4789936 T allele frequency between patient and control groups (OR = 0.68, 95% CI = 0.51-0.91, P = 0.009), which means lower risk of LAA stroke. We observed the rs4789936 had a decreased risk of LAA stroke according to the codominant (OR = 0.64, 95% CI = 0.44-0.92, P = 0.026), dominant (OR = 0.62, 95% CI = 0.43-0.88, P = 0.008), overdominant (OR = 0.68, 95% CI = 0.48-0.98, P = 0.039), log-additive (OR = 0.68, 95% CI = 0.51-0.91, P = 0.009) models analyses. However, these findings could only validate under dominant model (OR = 0.65, 95% CI = 0.42-1.00, P = 0.049) after adjustment of gender and age. The results indicate a potential association between TIMP-2 variants and LAA stroke risk in southern Chinese Han population.
引用
收藏
页码:4698 / 4706
页数:9
相关论文
共 44 条
[21]   Loss of flow induces leukocyte-mediated MMP/TIMP imbalance in dynamic in vitro blood-brain barrier model: role of pro-inflammatory cytokines [J].
Krizanac-Bengez, Ljiljana ;
Hossain, Mohammed ;
Fazio, Vince ;
Mayberg, Marc ;
Janigro, Damir .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (04) :C740-C749
[22]   Distribution profiles of membrane type-1 matrix metalloproteinase (MT1-MMP), matrix metalloproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: Comparison with plaque instability analysis [J].
Kuge, Yuji ;
Takai, Nozomi ;
Ishino, Seigo ;
Temma, Takashi ;
Shiomi, Masashi ;
Saji, Hideo .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (09) :1634-1640
[23]   Genes involved in innate immunity associated with asbestos-related fibrotic changes [J].
Kukkonen, Mari K. ;
Vehmas, Tapio ;
Piirila, Paivi ;
Hirvonen, Ari .
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 71 (01) :48-54
[24]  
Kurzawski M, 2017, ANDROLOGIA, P49
[25]   Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia [J].
Lorenzl, S ;
De Pasquale, G ;
Segal, AZ ;
Beal, MF .
STROKE, 2003, 34 (06) :E37-E38
[26]   Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke [J].
Manso, Helena ;
Krug, Tiago ;
Sobral, Joao ;
Albergaria, Isabel ;
Gaspar, Gisela ;
Ferro, Jose M. ;
Oliveira, Sofia A. ;
Vicente, Astrid M. .
BMC MEDICAL GENETICS, 2010, 11
[27]   Mechanisms and treatment of ischaemic stroke-insights from genetic associations [J].
Markus, Hugh S. ;
Bevan, Steve .
NATURE REVIEWS NEUROLOGY, 2014, 10 (12) :723-730
[28]   Genetic susceptibility to ischemic stroke [J].
Meschia, James F. ;
Worrall, Bradford B. ;
Rich, Stephen S. .
NATURE REVIEWS NEUROLOGY, 2011, 7 (07) :369-378
[29]   Matrix metalloproteinase inhibition therapy for vascular diseases [J].
Newby, Andrew C. .
VASCULAR PHARMACOLOGY, 2012, 56 (5-6) :232-244
[30]   Domain interactions in the gelatinase A•TIMP-2•MT1-MMP activation complex -: The ectodomain of the 44-kDa form of membrane type-I matrix metalloproteinase does not modulate gelatinase A activation [J].
Overall, CM ;
Tam, E ;
McQuibban, GA ;
Morrison, C ;
Wallon, UM ;
Bigg, HF ;
King, AE ;
Roberts, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) :39497-39506